Next Generation Sequencing (NGS) is the most important technical innovation of the past decade. Enzymes involved in NGS are not only required to have high specificity and fidelity, but also robustness to deliver reliable sequencing data. abm is one of the first few companies in the world to initiate R&D on enzymes required for NGS. To date, abm has developed a comprehensive range of NGS enzymes and kits to meet the most stringent needs. With the establishment of a reliable platform for the enzymes' design, production and validation, our NGS products provide top notch, consistent performance while being offered at incredibly competitive prices.